You are here:Home>Cervical Cancer Awareness Week – 21 – 27 January 2019
January 21-27 is Cervical Cancer Prevention Week, and to mark the event, the Informa Pharma Intelligence Report Store is offering 20% off of the following essential cervical cancer market reports. Just enter the following voucher code at checkout to receive 20% discount: cervical20
Cervical cancer is a major gynecological cancer which involves uncontrolled cell division and tissue invasiveness of the female uterine cervix. Incidence rates are highest in sub-Saharan Africa, Latin America and the Caribbean, and Oceania/Australasia, and lowest in Western Asia, Australia/New Zealand, and Northern America. Human papillomavirus (HPV) is a major cause of the main types of cervical cancer (the two main histological subtypes being squamous cell cancer and adenocarcinoma), and is believed to be responsible for around 95% of cervical cancers.
This Market Spotlight report covers the cervical cancer market, comprising key pipeline and marketed drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726